Opko Health traded at $2.63 this Friday July 1st, increasing $0.10 or 3.95 percent since the previous trading session. Looking back, over the last four weeks, Opko Health gained 14.89 percent. Over the last 12 months, its price fell by 34.41 percent. Looking ahead, we forecast Opko Health to be priced at 2.56 by the end of this quarter and at 2.36 in one year, according to Trading Economics global macro models projections and analysts expectations.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Abbott 110.22 1.57 1.45% -6.62%
Acadia Pharmaceuticals 14.37 0.28 1.99% -40.86%
Acorda Therapeutics 0.48 0.01 3.20% -89.34%
Agios Pharmaceuticals 23.36 1.19 5.37% -58.08%
Akebia Therapeutics 0.39 0.04 10.17% -89.51%
ALKERMES 30.53 0.74 2.48% 20.67%
Alnylam Pharmaceuticals 148.25 2.40 1.65% -13.52%
Amarin 1.44 -0.05 -3.36% -67.20%
Ardelyx 0.59 0.004 0.70% -92.47%
Arrowhead Research 35.96 0.75 2.13% -43.04%
Bluebird Bio 4.28 0.14 3.38% -86.36%
BioMarin Pharmaceutical 84.98 2.11 2.55% -0.57%
Bristol-Myers Squibb 76.84 -0.16 -0.21% 14.77%
Coherus Biosciences 7.83 0.59 8.15% -42.97%
Quest Diagnostics 136.68 3.70 2.78% 2.52%
Emergent BioSolutions 31.83 0.79 2.55% -50.08%
Esperion Therapeutics 6.45 0.09 1.42% -68.52%
Exact Sciences 41.13 1.74 4.42% -66.51%
Exelixis 21.57 0.75 3.60% 18.13%
Halozyme Therapeutics 44.48 0.48 1.09% -4.18%
Intercept Pharmaceuticals 14.13 0.32 2.32% -29.31%
Insmed 20.89 1.17 5.93% -26.70%
Ionis Pharmaceuticals 38.06 1.04 2.81% -4.66%
Ironwood Pharmaceuticals 11.53 0 0% -8.35%
Laboratory Of America 240.94 6.58 2.81% -13.32%
Lexicon Pharmaceuticals 1.94 0.08 4.30% -52.91%
Moderna Inc 149.95 7.10 4.97% -36.00%
Myriad Genetics 18.63 0.46 2.53% -40.48%
Neurocrine Biosciences 99.25 1.77 1.82% 0.65%
Opko Health 2.63 0.10 3.95% -34.41%
Puma Biotechnology 2.78 -0.07 -2.46% -68.48%
PTC Therapeutics 41.85 1.79 4.47% -2.88%
Ultragenyx Pharmaceutical 62.65 2.99 5.01% -33.50%
Seattle Genetics 180.11 3.17 1.79% 14.52%
Sarepta Therapeutics 75.71 0.75 1.00% 0.62%
Teva Pharmaceutical Industries 7.89 0.37 4.92% -19.74%
United Therapeutics 238.00 2.36 1.00% 29.12%
Vanda Pharmaceuticals 11.19 0.29 2.66% -46.25%

Indexes Price Day Year
US2000 1728 19.77 1.16% -25.07%

Opko Health
OPKO Health, Inc. is a healthcare company. Its segments include Diagnostics and Pharmaceutical. The Pharmaceutical segment consists of the pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain. The Diagnostics segment consists of the clinical laboratory operations of Bio-Reference Laboratories (Bio-Reference) and its point-of-care operations. Through Bio-Reference, it operates laboratory divisions, such as Bio-Reference, GenPath (Oncology), GenPath (Women's Health) and GeneDx. Its Pharmaceutical Business have one commercial stage pharmaceutical product and several pharmaceutical compounds and technologies in various stages of research and development for a range of indications and conditions, including Renal Products, Oxyntomodulin, Biologics, Factor VIIa -CTP, hGH-CTP. It also owns an active pharmaceutical ingredients (APIs) manufacturer in Israel through its subsidiary FineTech Pharmaceutical, Ltd.